世界のP2X7受容体拮抗薬市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global P2X7 Receptor Antagonists Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12547 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、P2X7受容体拮抗薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。P2X7受容体拮抗薬の種類別市場規模（GSK1482160、AZD9056、EVT 401、JNJ 55308942＆JNJ 54175446、AKP-23494954 / RQ-00466479、その他）、用途別市場規模（炎症性疾患、中枢神経系疾患、免疫系障害）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・P2X7受容体拮抗薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：GlaxoSmithKline、AstraZeneca、Janssen、RaQualia Pharma、Evotec、Asahi Kasei Pharma、Pfizer ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：GSK1482160、AZD9056、EVT 401、JNJ 55308942＆JNJ 54175446、AKP-23494954 / RQ-00466479、その他 ・用途別分析2016年-2026年：炎症性疾患、中枢神経系疾患、免疫系障害 ・P2X7受容体拮抗薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・P2X7受容体拮抗薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・P2X7受容体拮抗薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・P2X7受容体拮抗薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・P2X7受容体拮抗薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The P2X7 Receptor Antagonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global P2X7 Receptor Antagonists size is estimated to be USD 82 million in 2026 from USD 56 million in 2020, with a change XX% between 2020 and 2021. The global P2X7 Receptor Antagonists market size is expected to grow at a CAGR of 10.0% for the next five years.

Market segmentation
P2X7 Receptor Antagonists market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
GSK1482160
AZD9056
EVT 401
JNJ 55308942 & JNJ 54175446
AKP-23494954/RQ-00466479
Others

Market segment by Application, can be divided into
Inflammatory Diseases
Central Nervous System Diseases
Immune System Disorders

Market segment by players, this report covers
GlaxoSmithKline
AstraZeneca
Janssen
RaQualia Pharma
Evotec
Asahi Kasei Pharma
Pfizer

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of P2X7 Receptor Antagonists
1.2 Classification of P2X7 Receptor Antagonists by Type
1.2.1 Overview: Global P2X7 Receptor Antagonists Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global P2X7 Receptor Antagonists Revenue Market Share by Type in 2020
1.2.3 GSK1482160
1.2.4 AZD9056
1.2.5 EVT 401
1.2.6 JNJ 55308942 & JNJ 54175446
1.2.7 AKP-23494954/RQ-00466479
1.2.8 Others
1.3 Global P2X7 Receptor Antagonists Market by Application
1.3.1 Overview: Global P2X7 Receptor Antagonists Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Inflammatory Diseases
1.3.3 Central Nervous System Diseases
1.3.4 Immune System Disorders
1.4 Global P2X7 Receptor Antagonists Market Size & Forecast
1.5 Global P2X7 Receptor Antagonists Market Size and Forecast by Region
1.5.1 Global P2X7 Receptor Antagonists Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global P2X7 Receptor Antagonists Market Size by Region, (2016-2021)
1.5.3 North America P2X7 Receptor Antagonists Market Size and Prospect (2016-2026)
1.5.4 Europe P2X7 Receptor Antagonists Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific P2X7 Receptor Antagonists Market Size and Prospect (2016-2026)
1.5.6 South America P2X7 Receptor Antagonists Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa P2X7 Receptor Antagonists Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 P2X7 Receptor Antagonists Market Drivers
1.6.2 P2X7 Receptor Antagonists Market Restraints
1.6.3 P2X7 Receptor Antagonists Trends Analysis
2 Company Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline P2X7 Receptor Antagonists Product and Solutions
2.1.4 GlaxoSmithKline P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 GlaxoSmithKline Recent Developments and Future Plans
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca P2X7 Receptor Antagonists Product and Solutions
2.2.4 AstraZeneca P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 AstraZeneca Recent Developments and Future Plans
2.3 Janssen
2.3.1 Janssen Details
2.3.2 Janssen Major Business
2.3.3 Janssen P2X7 Receptor Antagonists Product and Solutions
2.3.4 Janssen P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Janssen Recent Developments and Future Plans
2.4 RaQualia Pharma
2.4.1 RaQualia Pharma Details
2.4.2 RaQualia Pharma Major Business
2.4.3 RaQualia Pharma P2X7 Receptor Antagonists Product and Solutions
2.4.4 RaQualia Pharma P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 RaQualia Pharma Recent Developments and Future Plans
2.5 Evotec
2.5.1 Evotec Details
2.5.2 Evotec Major Business
2.5.3 Evotec P2X7 Receptor Antagonists Product and Solutions
2.5.4 Evotec P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Evotec Recent Developments and Future Plans
2.6 Asahi Kasei Pharma
2.6.1 Asahi Kasei Pharma Details
2.6.2 Asahi Kasei Pharma Major Business
2.6.3 Asahi Kasei Pharma P2X7 Receptor Antagonists Product and Solutions
2.6.4 Asahi Kasei Pharma P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Asahi Kasei Pharma Recent Developments and Future Plans
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer P2X7 Receptor Antagonists Product and Solutions
2.7.4 Pfizer P2X7 Receptor Antagonists Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Pfizer Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global P2X7 Receptor Antagonists Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 P2X7 Receptor Antagonists Players Market Share
3.2.2 Top 10 P2X7 Receptor Antagonists Players Market Share
3.2.3 Market Competition Trend
3.3 P2X7 Receptor Antagonists Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global P2X7 Receptor Antagonists Revenue and Market Share by Type (2016-2021)
4.2 Global P2X7 Receptor Antagonists Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global P2X7 Receptor Antagonists Revenue Market Share by Application (2016-2021)
5.2 P2X7 Receptor Antagonists Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America P2X7 Receptor Antagonists Revenue by Type (2016-2026)
6.2 North America P2X7 Receptor Antagonists Revenue by Application (2016-2026)
6.3 North America P2X7 Receptor Antagonists Market Size by Country
6.3.1 North America P2X7 Receptor Antagonists Revenue by Country (2016-2026)
6.3.2 United States P2X7 Receptor Antagonists Market Size and Forecast (2016-2026)
6.3.3 Canada P2X7 Receptor Antagonists Market Size and Forecast (2016-2026)
6.3.4 Mexico P2X7 Receptor Antagonists Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe P2X7 Receptor Antagonists Revenue by Type (2016-2026)
7.2 Europe P2X7 Receptor Antagonists Revenue by Application (2016-2026)
7.3 Europe P2X7 Receptor Antagonists Market Size by Country
7.3.1 Europe P2X7 Receptor Antagonists Revenue by Country (2016-2026)
7.3.2 Germany P2X7 Receptor Antagonists Market Size and Forecast (2016-2026)
7.3.3 France P2X7 Receptor Antagonists Market Size and Forecast (2016-2026)
7.3.4 United Kingdom P2X7 Receptor Antagonists Market Size and Forecast (2016-2026)
7.3.5 Russia P2X7 Receptor Antagonists Market Size and Forecast (2016-2026)
7.3.6 Italy P2X7 Receptor Antagonists Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific P2X7 Receptor Antagonists Revenue by Type (2016-2026)
8.2 Asia-Pacific P2X7 Receptor Antagonists Revenue by Application (2016-2026)
8.3 Asia-Pacific P2X7 Receptor Antagonists Market Size by Region
8.3.1 Asia-Pacific P2X7 Receptor Antagonists Revenue by Region (2016-2026)
8.3.2 China P2X7 Receptor Antagonists Market Size and Forecast (2016-2026)
8.3.3 Japan P2X7 Receptor Antagonists Market Size and Forecast (2016-2026)
8.3.4 South Korea P2X7 Receptor Antagonists Market Size and Forecast (2016-2026)
8.3.5 India P2X7 Receptor Antagonists Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia P2X7 Receptor Antagonists Market Size and Forecast (2016-2026)
8.3.7 Australia P2X7 Receptor Antagonists Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America P2X7 Receptor Antagonists Revenue by Type (2016-2026)
9.2 South America P2X7 Receptor Antagonists Revenue by Application (2016-2026)
9.3 South America P2X7 Receptor Antagonists Market Size by Country
9.3.1 South America P2X7 Receptor Antagonists Revenue by Country (2016-2026)
9.3.2 Brazil P2X7 Receptor Antagonists Market Size and Forecast (2016-2026)
9.3.3 Argentina P2X7 Receptor Antagonists Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa P2X7 Receptor Antagonists Revenue by Type (2016-2026)
10.2 Middle East & Africa P2X7 Receptor Antagonists Revenue by Application (2016-2026)
10.3 Middle East & Africa P2X7 Receptor Antagonists Market Size by Country
10.3.1 Middle East & Africa P2X7 Receptor Antagonists Revenue by Country (2016-2026)
10.3.2 Turkey P2X7 Receptor Antagonists Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia P2X7 Receptor Antagonists Market Size and Forecast (2016-2026)
10.3.4 UAE P2X7 Receptor Antagonists Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global P2X7 Receptor Antagonists Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global P2X7 Receptor Antagonists Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market P2X7 Receptor Antagonists Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global P2X7 Receptor Antagonists Revenue (USD Million) by Region (2016-2021)
Table 5. Global P2X7 Receptor Antagonists Revenue Market Share by Region (2021-2026)
Table 6. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 7. GlaxoSmithKline Major Business
Table 8. GlaxoSmithKline P2X7 Receptor Antagonists Product and Solutions
Table 9. GlaxoSmithKline P2X7 Receptor Antagonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 11. AstraZeneca Major Business
Table 12. AstraZeneca P2X7 Receptor Antagonists Product and Solutions
Table 13. AstraZeneca P2X7 Receptor Antagonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Janssen Corporate Information, Head Office, and Major Competitors
Table 15. Janssen Major Business
Table 16. Janssen P2X7 Receptor Antagonists Product and Solutions
Table 17. Janssen P2X7 Receptor Antagonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. RaQualia Pharma Corporate Information, Head Office, and Major Competitors
Table 19. RaQualia Pharma Major Business
Table 20. RaQualia Pharma P2X7 Receptor Antagonists Product and Solutions
Table 21. RaQualia Pharma P2X7 Receptor Antagonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Evotec Corporate Information, Head Office, and Major Competitors
Table 23. Evotec Major Business
Table 24. Evotec P2X7 Receptor Antagonists Product and Solutions
Table 25. Evotec P2X7 Receptor Antagonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Asahi Kasei Pharma Corporate Information, Head Office, and Major Competitors
Table 27. Asahi Kasei Pharma Major Business
Table 28. Asahi Kasei Pharma P2X7 Receptor Antagonists Product and Solutions
Table 29. Asahi Kasei Pharma P2X7 Receptor Antagonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Pfizer Corporate Information, Head Office, and Major Competitors
Table 31. Pfizer Major Business
Table 32. Pfizer P2X7 Receptor Antagonists Product and Solutions
Table 33. Pfizer P2X7 Receptor Antagonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Global P2X7 Receptor Antagonists Revenue (USD Million) by Players (2019-2021)
Table 35. Global P2X7 Receptor Antagonists Revenue Share by Players (2019-2021)
Table 36. Breakdown of P2X7 Receptor Antagonists by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. P2X7 Receptor Antagonists Players Head Office, Products and Services Provided
Table 38. P2X7 Receptor Antagonists Mergers & Acquisitions in the Past Five Years
Table 39. P2X7 Receptor Antagonists New Entrants and Expansion Plans
Table 40. Global P2X7 Receptor Antagonists Revenue (USD Million) by Type (2016-2021)
Table 41. Global P2X7 Receptor Antagonists Revenue Share by Type (2016-2021)
Table 42. Global P2X7 Receptor Antagonists Revenue Forecast by Type (2021-2026)
Table 43. Global P2X7 Receptor Antagonists Revenue by Application (2016-2021)
Table 44. Global P2X7 Receptor Antagonists Revenue Forecast by Application (2021-2026)
Table 45. North America P2X7 Receptor Antagonists Revenue by Type (2016-2021) & (USD Million)
Table 46. North America P2X7 Receptor Antagonists Revenue by Type (2021-2026) & (USD Million)
Table 47. North America P2X7 Receptor Antagonists Revenue by Application (2016-2021) & (USD Million)
Table 48. North America P2X7 Receptor Antagonists Revenue by Application (2021-2026) & (USD Million)
Table 49. North America P2X7 Receptor Antagonists Revenue by Country (2016-2021) & (USD Million)
Table 50. North America P2X7 Receptor Antagonists Revenue by Country (2021-2026) & (USD Million)
Table 51. Europe P2X7 Receptor Antagonists Revenue by Type (2016-2021) & (USD Million)
Table 52. Europe P2X7 Receptor Antagonists Revenue by Type (2021-2026) & (USD Million)
Table 53. Europe P2X7 Receptor Antagonists Revenue by Application (2016-2021) & (USD Million)
Table 54. Europe P2X7 Receptor Antagonists Revenue by Application (2021-2026) & (USD Million)
Table 55. Europe P2X7 Receptor Antagonists Revenue by Country (2016-2021) & (USD Million)
Table 56. Europe P2X7 Receptor Antagonists Revenue by Country (2021-2026) & (USD Million)
Table 57. Asia-Pacific P2X7 Receptor Antagonists Revenue by Type (2016-2021) & (USD Million)
Table 58. Asia-Pacific P2X7 Receptor Antagonists Revenue by Type (2021-2026) & (USD Million)
Table 59. Asia-Pacific P2X7 Receptor Antagonists Revenue by Application (2016-2021) & (USD Million)
Table 60. Asia-Pacific P2X7 Receptor Antagonists Revenue by Application (2021-2026) & (USD Million)
Table 61. Asia-Pacific P2X7 Receptor Antagonists Revenue by Region (2016-2021) & (USD Million)
Table 62. Asia-Pacific P2X7 Receptor Antagonists Revenue by Region (2021-2026) & (USD Million)
Table 63. South America P2X7 Receptor Antagonists Revenue by Type (2016-2021) & (USD Million)
Table 64. South America P2X7 Receptor Antagonists Revenue by Type (2021-2026) & (USD Million)
Table 65. South America P2X7 Receptor Antagonists Revenue by Application (2016-2021) & (USD Million)
Table 66. South America P2X7 Receptor Antagonists Revenue by Application (2021-2026) & (USD Million)
Table 67. South America P2X7 Receptor Antagonists Revenue by Country (2016-2021) & (USD Million)
Table 68. South America P2X7 Receptor Antagonists Revenue by Country (2021-2026) & (USD Million)
Table 69. Middle East & Africa P2X7 Receptor Antagonists Revenue by Type (2016-2021) & (USD Million)
Table 70. Middle East & Africa P2X7 Receptor Antagonists Revenue by Type (2021-2026) & (USD Million)
Table 71. Middle East & Africa P2X7 Receptor Antagonists Revenue by Application (2016-2021) & (USD Million)
Table 72. Middle East & Africa P2X7 Receptor Antagonists Revenue by Application (2021-2026) & (USD Million)
Table 73. Middle East & Africa P2X7 Receptor Antagonists Revenue by Country (2016-2021) & (USD Million)
Table 74. Middle East & Africa P2X7 Receptor Antagonists Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. P2X7 Receptor Antagonists Picture
Figure 2. Global P2X7 Receptor Antagonists Revenue Market Share by Type in 2020
Figure 3. GSK1482160
Figure 4. AZD9056
Figure 5. EVT 401
Figure 6. JNJ 55308942 & JNJ 54175446
Figure 7. AKP-23494954/RQ-00466479
Figure 8. Others
Figure 9. P2X7 Receptor Antagonists Revenue Market Share by Application in 2020
Figure 10. Inflammatory Diseases Picture
Figure 11. Central Nervous System Diseases Picture
Figure 12. Immune System Disorders Picture
Figure 13. Global P2X7 Receptor Antagonists Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global P2X7 Receptor Antagonists Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global P2X7 Receptor Antagonists Revenue Market Share by Region (2016-2026)
Figure 16. Global P2X7 Receptor Antagonists Revenue Market Share by Region in 2020
Figure 17. North America P2X7 Receptor Antagonists Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe P2X7 Receptor Antagonists Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific P2X7 Receptor Antagonists Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America P2X7 Receptor Antagonists Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Middle East and Africa P2X7 Receptor Antagonists Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. P2X7 Receptor Antagonists Market Drivers
Figure 23. P2X7 Receptor Antagonists Market Restraints
Figure 24. P2X7 Receptor Antagonists Market Trends
Figure 25. GlaxoSmithKline Recent Developments and Future Plans
Figure 26. AstraZeneca Recent Developments and Future Plans
Figure 27. Janssen Recent Developments and Future Plans
Figure 28. RaQualia Pharma Recent Developments and Future Plans
Figure 29. Evotec Recent Developments and Future Plans
Figure 30. Asahi Kasei Pharma Recent Developments and Future Plans
Figure 31. Pfizer Recent Developments and Future Plans
Figure 32. Global P2X7 Receptor Antagonists Revenue Share by Players in 2020
Figure 33. P2X7 Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players P2X7 Receptor Antagonists Revenue Market Share in 2020
Figure 35. Global Top 10 Players P2X7 Receptor Antagonists Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global P2X7 Receptor Antagonists Revenue Share by Type in 2020
Figure 38. Global P2X7 Receptor Antagonists Market Share Forecast by Type (2021-2026)
Figure 39. Global P2X7 Receptor Antagonists Revenue Share by Application in 2020
Figure 40. Global P2X7 Receptor Antagonists Market Share Forecast by Application (2021-2026)
Figure 41. North America P2X7 Receptor Antagonists Sales Market Share by Type (2016-2026)
Figure 42. North America P2X7 Receptor Antagonists Sales Market Share by Application (2016-2026)
Figure 43. North America P2X7 Receptor Antagonists Revenue Market Share by Country (2016-2026)
Figure 44. United States P2X7 Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada P2X7 Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico P2X7 Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe P2X7 Receptor Antagonists Sales Market Share by Type (2016-2026)
Figure 48. Europe P2X7 Receptor Antagonists Sales Market Share by Application (2016-2026)
Figure 49. Europe P2X7 Receptor Antagonists Revenue Market Share by Country (2016-2026)
Figure 50. Germany P2X7 Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France P2X7 Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom P2X7 Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia P2X7 Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy P2X7 Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific P2X7 Receptor Antagonists Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific P2X7 Receptor Antagonists Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific P2X7 Receptor Antagonists Revenue Market Share by Region (2016-2026)
Figure 58. China P2X7 Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan P2X7 Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea P2X7 Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India P2X7 Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia P2X7 Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia P2X7 Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America P2X7 Receptor Antagonists Sales Market Share by Type (2016-2026)
Figure 65. South America P2X7 Receptor Antagonists Sales Market Share by Application (2016-2026)
Figure 66. South America P2X7 Receptor Antagonists Revenue Market Share by Country (2016-2026)
Figure 67. Brazil P2X7 Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina P2X7 Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa P2X7 Receptor Antagonists Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa P2X7 Receptor Antagonists Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa P2X7 Receptor Antagonists Revenue Market Share by Country (2016-2026)
Figure 72. Turkey P2X7 Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia P2X7 Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE P2X7 Receptor Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source

---